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Discussion Summaries
Abstract
Acute upper gastrointestinal bleeding (AUGIB) is one of the most common emergencies
encountered by gastroenterologists across the world. Various medical and endoscopic therapies
have evolved over time to improve patient outcomes. However, controversy still exists around the
optimal time of endoscopy for patients with AUGIB. Recently, several studies have been published
to answer this clinical question and we have reviewed one of these articles.
On 13th October 2021, @Gijournal, we discussed the latest high-impact article published to
answer this clinical question. We critically appraised, ‘’Timing of endoscopy for acute upper
gastrointestinal bleeding: a territory-wide cohort study’’ which was published in ‘Gut’ on Sep 21
by Cosmos L T Guo et al. This is a brief review of this article and subsequent discussion around
it. This session was moderated by Shima Ghavimi, and experts were Cosmos L T Guo, Louis H S
Lau, and Rashid N S Lui who were also authors of this paper.

Discussion Summary
Background

Acute Upper gastrointestinal bleeding (AUGIB) is one of the most common medical emergencies
encountered by gastroenterologists. Medical and endoscopic management has improved outcomes
over the years, but incidence remains high. Currently. It is recommended that endoscopy should
be performed in first 24 hours (1, 2). A randomized controlled trial published by same group
recently didn’t show any benefit of early endoscopy done within 6 hours (3).
To move another step forward, the authors published this study to answer key questions around
timing of endoscopy and its impact on patient outcomes. This was a retrospective analysis of
electronic records of all patients admitted with AUGIB from all public hospitals in Hong Kong
between 2013-2019. Patients were divided into three groups based on their time of endoscopy from
admission, urgent with EGD done from 0-6hrs, early group from 06-24hrs and late from 24-48
hrs. The bleeding severity was determined by modified Glasgow-Blatchford Score (GBS). The
inverse probability of treatment weighting (IPTW) was employed to adjust for the baseline
characteristics.

Primary outcome of the study was 30-day all-cause mortality rate. Secondary outcome was need
of repeating therapeutic endoscopy within 30 days , average units of blood transfused within 30
days , Intensive care unit (ICU) admission within 30 days, in-hospital mortality rate as well as
length of stay in hospital.
In total there were 6,474 patients in the study. Urgent group (<6hr) had 1,008 with mean EGD
time of 4.08 hours, early group had 3,865 patients with mean EGD time of 15.6 hours and late
group had 1,601 patients with mean EGD time 32.3 hours.
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In most of the results, early group was used as baseline as they had lowest mortality. Urgent group
of patients showed highest mortality (aHR of 1.43 - 95% CI 1.24 to 1.65, p<0.001) and mortality
was still high in late group- aHR of 1.25 (95% CI 1.078 to 1.449, p=0.003). There were more
deaths seen in urgent and late group as compared to early group (Urgent - 6.2% vs early 4.3%,
p=0.017 late - 5.8% vs early 4.3%, p=0.022).
In secondary outcomes, early group was again used as reference. Thirty day repeat endoscopy rates
were higher in urgent and late group as well (Urgent – aHR - 1.215 p<0.001; Late – aHR - 1.040
p=0.426). Thirty-day ICU admission were higher in urgent group but lower in late group of patients
(Urgent – aHR- 1.403 p <0.001 Late – aHR - 0.716 p=0.002).
Looking through the patient characteristics, urgent group had more comorbidities. However, even
those without significant comorbidity had higher 30-day all-cause mortality compared to early
group (aHR.1.69 p<0.001) and higher 30-day ICU admission (aHR 1.55 p<0.001).
In subgroup analysis, there were 286 patients with variceal bleeding as compared to 6188 with
non-variceal. It’s important to note that there were no significant outcomes in urgent and early
group. Late group was associated with higher 30-day mortality in variceal group. In sub group
analysis, there was no significant effect of weekend admission on the association between timing
and clinical outcomes.
The strength of this study was the large sample size which allowed for a robust statistical analysis.
The limitations were lack of some initial data for blood pressure, pulse and clinical data of syncope
which was key component of modified GBS score. The data wasn’t robust to show any significant
impact on variceal bleeding and time of endoscopy.
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Summary of Article: by (AA)
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Discussion:
First Poll (232 votes)
SG: 54 y/o male with PmHx of HTN and DM came to the ER, with c/o hematemesis, no Hx of
liver diseases, has hx of NSAID use, BP:100/80, HR, 110, Hb:11 from baseline 13. \What would
you do next?


Transfuse Blood (0.9%)



Admit to MICU (3%)



Resuscitate + Fluids+PPI (88.8%)



Endoscopy within 6 hrs (7.3%)

2nd Poll (121 votes)
SG: After resuscitation for the patient above, GI team was called. When would YOU consider
EGD for this patient?


<6 hours (10.7%)



6 to 12 hours (17.4%)



6 to 24 hours (64.5%)



24 to 48 hours (7.4%)

UK(@UmairKamran11): What do experts think is the reason of difference in outcomes? If I have
rightly understood, baseline pulse and BP were not different between groups so can’t say that
urgent group was not resuscitated properly.

RL: There may be processes like hemodynamical dysfunction, ongoing bleeding that are not fully
captured by baseline vitals. Also 55% missing is quite high for using multiple imputations and is
a drawback for our study.

SM:
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1. Patients can become unstable during procedure leading to aborting the procedure
2. Incomplete visualization. Erythromycin and Reglan would be great but difficult to time with
endoscopy. Rarely saw them being used in practice.
3rd Poll
Does the timing of endoscopy affect clinical outcomes in patients presenting with acute upper
gastrointestinal bleeding ? (80 votes)
Yes (75%)
No (20%)
Explain in comments (5%)

SM (@SultanMahmoodMD): I was beginning to think that timing doesn’t make a difference based
on recent RCTs. However, this study did show worse outcomes for late group.

RL: I think someone brought that up before. If it's not weekends or something else, we measured,
maybe it was other confounding like #ACS, sepsis, need to withhold anti-platelet agents/ anticoagulants etc. Though it's possible that in these cases the prognosis was poor to begin with.

RI: A good and fair point. The @Gut_BMJ paper drew data from the entire #HongKong so there
would be variations in practice. In our centre at @CUHKMedicine there is 24/7 urgent coverage.
But we did look at the weekend effect in sensitivity analyses, there were no big surprises.

SM: Are there other studies which show that delayed endoscopy >24 hr after admission is
associated with worse outcomes?

DK (@GI_Pearls): Hard to remove confounding in such (clearly non-randomized studies). In
many hospitals if endoscopy is delayed, there may be a medical reason for it (active MI, some
other ICU mishap, etc, which would make mortality high.

LL: Fully agree. The ‘late’ group could have various reasons for delaying their endoscopies, for
example, other concurrent medical illness like cardiac or septic conditions, which will increase the
overall mortality.
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SM: My initial thought too. Before IPTW higher GBS score and more cardiac disease in late group.
Makes me wonder if timing makes a difference at all. I know we were delaying endoscopy for a
lot of COVID pts who did fine even without it.
SG: Patients admitted on the weekend for PUD hemorrhage have higher mortality and more
frequently undergo surgery. Wait times for EGD are prolonged in patients hospitalized on the
weekend, this delay does not appear to mediate the weekend effect (4).

RL: True. No matter how rigorous the matching was, non-randomised studies have their
limitations.

SG: Confounding is less likely when researching rare but serious harms, which are very difficult
to investigate with #RCTs. #NRS may have a valuable role in this context (5).

4th Poll
SG: Based on this study would you change your practice (33 votes)


Yes (33.3%)



NO (48.5%)



Not Sure yet (18.2%)

SG: Details about endoscopy report is crucial.

RL: Clip near the vessel for marking if needed to help our IR docs visualize better!

SG: Be specific w lesions: size, depth, classification if ulcers, red wale or SRH if varices, and
difficulty (Unapproachable post bulbar location? Big clot in fundus? Should be intubated if
rebleeds?) Things that would help others pick up where you left off, why, what to do.

SG: Under the rebleed plan, I would briefly document any discussions that have already taken
place with surgeons or IR to make it easier for the next person who gets called about the rebleed.
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SG: Also, put in instructions to avoid medications like NSAIDs for ulcer disease and mark
specimen/site of sample.

Image 1: Essentials of AUGIB endoscopy report (Courtesy of @drkeithsiau)

5th Poll
Which of the following is the most common cause of #NVUGIB? (38 votes)
Dieulafoy's lesion (0%)
GAVE (0%)
Mallory-Weiss tear (7.9%)
Peptic Ulcer Disease (92.1%)
@Gijournal Volume 1 Issue 13 November 2021

Discussion Summaries
LL: With the increasing awareness of HP eradication and NSAID’s harm, we observed an
increasing trend in idiopathic ulcers. They are more prone to rebleed and more lethal (6).

LL: Our previous RCT on this condition showed a numerically lower rebleeding rate in PPI group
(0.88% vs 2.62%) over a follow-up period of 24 months (7).

SG: There are many well-established causes and some associated factors related to its
development, the most important being: NSAIDs/aspirin, direct chemical/erosive agents, H. pylori
and neoplasm.

SG: Image 2 (8)
Etiologies of Peptic Ulcer Disease (Courtesy of @RashidLui )
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SG: “Risk stratification is important to determine the indication for treatment and predict clinical
outcome. Early identification of high-risk patients is essential for intensive management and preemptive intervention” (9).

6th Poll (13 votes)
Do you know about Care Bundles?
Yes (23.1%)
No (76.9%)
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SG: Care bundles comprise a pragmatic series of evidence-based interventions, which when
performed together, lead to a better outcome than if performed individually (10).
https://fg.bmj.com/content/11/4/311
SG: We classify the endoscopic appearance of ulcers by the Forrest classification with great
examples by @EndoscopyCampus https://www.endoscopycampus.com/en/classifications/forrest-classification/
Image 3 (11): Forrest Classification of Upper GI Bleeding

Other Key elements of discussion:
SM: I think for the most part this study adds more data backing up the current practice of avoiding
emergent endoscopy which is unlikely to improve outcomes

RL: Vast majority of cases really don't require urgent endoscopy. Need to consider separately for
those that do not respond to resuscitation, active hematemesis, or variceal bleeders (i.e. known
advanced fibrosis/cirrhosis/HCC, portal HT, portal vein thromboses etc.
IA (@ijlalakbar): I have a question re PPI. Current guidelines suggest BID PPI before EGD and
then drip if intervention done. @NEJM paper had drip for everyone to start with. What was the
case here and what is your practice?

RL: Good Q. I can only guess that more severe bleeds likely had IV infusions. Less severe the
practice is more variable. In #HongKong we like our pre-endoscopy PPI infusions The latest
guidelines suggest against routine use because another RCT in @NEJM only showed downstaging
of Endoscopic lesions. But the lack of evidence is not evidence that it doesn’t work. And I
personally think that downstaging lesions is great. More time to diagnose, take biopsies etc.
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Especially pertinent in rural settings or in vast countries. Maybe less impactful in metropolitan
areas

DS (@drdalbir): I would add that in addition to IV fluids, resuscitation in patients with
active/witnessed hematemesis, I have low threshold for admitting these patients to MICU and
elective intubation.

SG: Patients with recurrent bleeding generally respond favourably to repeat endoscopic therapy.
Routine second-look endoscopy, defined as a planned endoscopy within 24 hours of the initial
endoscopy, is not recommended.

AT (@DrBloodandGuts): Hemostatic powder applied as a primary modality for active bleeding
PUD (Forrest 1), will only reduce rebleed to that of an adherent clot (Forrest 2b, 30%) I
recommend relook in these cases for mechanical/ thermal durable hemostasis or IR mesenteric
angioembolization.

SM: Question for the authors. A majority of the patients >50% were getting early endoscopy (<6h).
This is definitely not the standard practice in the United States anymore. What is the current
protocol in China.

AA: Also noticed that more than 50% pts didn't have initial BP and pulse recorded. These are
important parameters in hemodynamic stability. How would these impact results in real life?
CG: The greatest concern here was whether the data was "missing not at random" (MNAR), which
would imply that the missing data could have been associated the patient's condition, such as the
severity of the bleeding. This would affect the validity of the imputation of data.
SG: Great point @CosmosGuo “if the results obtained #MNAR assumptions are similar, one can
conclude that the presence of unobserved factors does not affect the conclusion.

Conclusion:
In patients with non-variceal acute upper gastrointestinal bleeding, upper endoscopy performed
within 6 to 24 hours had significantly better outcomes, less 30-day mortality rate and less ICU
admission as compared to those who had endoscopy performed in less than 6 hrs or when
endoscopy was performed after 24 hrs. This research also highlights the importance of
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resuscitation and pharmacotherapy intervention before gastroenterology consultation for upper GI
endoscopy.
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